Ritter Pharmaceuticals Культура компании

Mr. Michael D. Step has been the Chief Executive Officer at Ritter Pharmaceuticals, Inc. since October 1, 2014. Mr. Step served as the Senior Vice President of Corporate Development at Santarus, Inc. from February 8, 2005 to January 2, 2014. He assumed responsibility for establishing additional strategic relationships to expand the promotion of Santarus' products in the U.S., to out-license Santarus Inc.'s proprietary technology outside the U.S., and to increase Santarus Inc.'s product portfolio with in-licensed or co-promoted specialty pharmaceutical products. He was responsible for leading all licensing and M&A activities at Santarus and was a member of its executive team. Prior to joining Santarus, he served as Vice President of Corporate Development of Amylin Pharmaceuticals, LLC since August 2002. In this capacity, he was responsible for leading corporate development activities, including product licensing, strategic planning and mergers and acquisitions evaluations. Mr. Step joined Amylin in July 2000 and until September 2001, he served as its Executive Director of Commercial Operations where he was responsible for developing the sales function for Amylin's future commercialization plans. Prior to this, he served as the Senior Director of Business Development at Dura Pharmaceuticals from 1998 to July 2000. From 1996 to 1998, Mr. Step served as an Associate Director of Business Development and Strategic Planning at Hoffmann-La Roche. From 1993 to 1996, he served in various licensing, management and sales roles for Syntex Laboratories and Roche Labs. He has more than 20 years of business experience, including 12 years in the pharmaceutical and biotechnology arena, including 8 years in corporate development positions. He has been a Director at Ritter Pharmaceuticals, Inc. since 2012. Mr. Step received his B.A. in Political Science from Vanderbilt University in 1981 and his M.B.A. in Marketing and Finance from Marshall School of Business, the University of Southern California in 1986.

Ms. Ellen F. Mochizuki has been Consultant of Ritter Pharmaceuticals, Inc. since October 31, 2017. Ms. Mochizuki served as the Principal Financial Officer at Ritter Pharmaceuticals, Inc. since November 1, 2015 until October 20, 2017 and served as its Principal Accounting Officer until October 13, 2017. Ms. Mochizuki served as Vice President of Finance at Ritter Pharmaceuticals, Inc. since September 18, 2015 until October 13, 2017. Ms. Mochizuki served as Senior Vice President of Indymac Bancorp Inc. Ms. Mochizuki consulted with various biopharmaceutical clients with respect to their initial public offerings and related financial statements. From 2007 to 2014, she was a Director of Accounting (Benefits) for Northrop Grumman Corporation, or NGC and was responsible for the overall accounting and accounting operations of its benefit assets. From 2006 to 2007, Ms. Mochizuki consulted with NGC. From 2002 to 2005, she was a Senior Vice President at IndyMac Bank, overseeing human resources operations. Ms. Mochizuki started her career as an auditor with PricewaterhouseCoopers. Ms. Mochizuki is an adjunct faculty at Pasadena City College teaching accounting (2014 to present) and is licensed in the State of California as a certified public accountant though is currently on inactive status.

Mr. Andrew J. Ritter Co-founded Ritter Pharmaceuticals, Inc in March 2008 and has been the President of Ritter Pharmaceuticals, Inc., since 2008. Mr. Ritter. Mr. Ritter served as Chief Executive Officer of Ritter Pharmaceuticals, Inc until October 2014. He has been actively studying the field of lactose intolerance for over 15 years. Since 2010, he has also acted as Managing Partner of Stonehenge Partners, a private investment fund which provides working capital and executive leadership to a variety of businesses and industries. Those industries include: Real Estate, Tech, Biotech, Entertainment and Service businesses. He serves as Secretary at Ritter Pharmaceuticals, Inc. He has been a Director at Ritter Pharmaceuticals, Inc. since 2008. He is a Guest Lecturer of entrepreneurship at various graduate and undergraduate schools throughout Los Angeles including: Marshall School of Business, University of Southern California, Anderson School of Business, University of California of Los Angeles and Pepperdine University Graziadio School of Business and Management. Los Angeles Mayor, Richard Riordan, appointed Mr. Ritter to serve as a Los Angeles City Commissioner from 2000 to 2002 (The youngest appointed Commissioner in Los Angeles history.). He was a Member of the 2002 Pac-10 Champion baseball team. Mr. Ritter holds a Bachelor Degree in Political Science and a minor in Business from the University of Southern California. He graduated from the Stanford Graduate School of Business??? Executive Education on Influence and Negotiation Strategies.

Mr. Ira E. Ritter has been the Executive Chairman and Chief Strategic Officer of Ritter Pharmaceuticals, Inc. since 2008. Mr. Ritter provides corporate management, strategic planning and financial consulting for a wide range of market segments. He serves as the Chief Executive Officer of Andela Group Inc. He co-founded Ritter Pharmaceuticals, Inc. in 2008. He has over 40 years experience creating, building and operating multi-faceted business enterprises. In the health and beauty sector, Mr. Ritter served as President and Vice-Chairman of Quality King Inc. He served as Chief Executive Officer, President and Chairman of Rockwood, a company that created private label brands for GNC and provided high-end in-house HBA products for other national retailers including K-Mart. In the personal services market, he grew a people-to-people business, Elite Personal Search and Lifemates personal matchmaking service, in the U.S. and Canada. From 1980 to 1985, he produced the first televised home shopping program and directed development of the largest ???pay-per-view??? channel system for its time. His experience also includes over fifteen years as Chief Executive Officer of RG Publishing where he published best-selling monthly national consumer magazines and of book publishing houses that included Pegasus, Front Row Center, Readers' Guild and Hampshire House, where he released over 200 book titles annually. Additionally, he was involved in telecommunications as Chairman of Oak Media, a division of Oak Industries. He served as Chairman of ON-TV. While operating its ONTV channel, he obtained the first home team broadcast rights for professional Los Angeles and Chicago sporting events. He served on the board of directors for the Martin Lawrence Art Galleries. He also has a long history of public service that includes appointments by three Governors to several State of California Commissions, including eight years served as Commissioner on the California Prison Industry Authority. In 1981, Mr. Ritter was honored with the City of Hope's Man of the Year award. During his 20 years as a publisher, he produced monthly national consumer magazines including Playgirl. and released books that included It's OK to Say No childrens??? series and Patti Regan Davis??? Homefront.

Diane Plotkin serves as the Vice President Clinical Development of Ritter Pharmaceuticals, Inc.. Diane started at Ritter Pharmaceuticals, Inc. in November of 2017. Diane currently resides in Greater Los Angeles Area.

Robert Tidwell serves as the Chief Business Officer of Ritter Pharmaceuticals, Inc.. Robert started at Ritter Pharmaceuticals, Inc. in November of 2011. Robert currently resides in Greater Los Angeles Area.